Loading...
XASE
AMS
Market cap9mUSD
Jul 09, Last price  
1.52USD
1D
3.06%
1Q
12.22%
Jan 2017
-54.78%
Name

American Shared Hospital Services

Chart & Performance

D1W1MN
XASE:AMS chart
P/E
P/S
0.36
EPS
Div Yield, %
Shrs. gr., 5y
1.37%
Rev. gr., 5y
9.50%
Revenues
28m
-0.91%
20,385,00022,622,00019,099,00016,768,00016,675,00022,221,00017,048,00017,584,00015,417,00016,548,00018,700,00019,556,00019,714,00020,605,00017,837,00017,628,00019,746,00021,325,00028,340,00028,082,000
Net income
-2m
L
1,656,000951,000477,000-188,00057,000506,00038,000-312,000-952,000-1,522,000930,0001,923,0001,023,000659,000-7,058,000194,0001,328,000610,0002,186,000-1,553,000
CFO
3m
+1,755.09%
9,164,0008,484,0008,947,0007,704,0007,184,0006,823,0006,871,0008,076,0006,773,0008,548,0008,378,0007,853,0008,062,0008,047,0009,745,0006,267,0007,235,0005,718,000167,0003,098,000
Dividend
Jun 28, 20070.0475 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

American Shared Hospital Services specializes in leasing advanced radiosurgery and radiation therapy equipment to healthcare providers. The company offers Gamma Knife stereotactic radiosurgery systems, a non-invasive technology used to treat conditions such as malignant and benign brain tumors, arteriovenous malformations, and trigeminal neuralgia. They also facilitate financing for Leksell Gamma Knife units. Additionally, the firm operates proton beam radiation therapy centers in Orlando, Florida, and Long Beach, California. Customers further benefit from comprehensive support encompassing planning, installation, reimbursement guidance, and marketing strategies. As of December 31, 2021, their portfolio included 115 active Gamma Knife units across the United States, complemented by two units in South America (Lima, Peru, and Guayaquil, Ecuador), and one proton beam radiation therapy system. Established in 1980, American Shared Hospital Services maintains its headquarters in San Francisco, California.
IPO date
Jul 04, 1984
Employees
28
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT